Les stents à élution de médicaments : preuves, incertitudes et pratiques

Serruys, 1994, A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group, N. Engl. J. Med., 331, 489, 10.1056/NEJM199408253310801 Fischman, 1994, A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent restenosis study investigators, N. Engl. J. Med., 331, 496, 10.1056/NEJM199408253310802 Cutlip, 2001, Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials, Circulation, 103, 1967, 10.1161/01.CIR.103.15.1967 Marx, 2001, Bench to bedside: the development of rapamycin and its application to stent restenosis, Circulation, 104, 852, 10.1161/01.CIR.104.8.852 Sousa, 2001, Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up, Circulation, 104, 2007, 10.1161/hc4201.098056 Degertekin, 2002, Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up, Circulation, 106, 1610, 10.1161/01.CIR.0000034447.02535.D5 Sousa, 2003, Two-year angiographic and intravascular ultrsond follow-up afeter implantation of sirolimus-eluting stents in human coronary arteries, Circulation, 107, 381, 10.1161/01.CIR.0000051720.59095.6D Morice, 2002, A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization, N. Engl. J. Med., 346, 1773, 10.1056/NEJMoa012843 Moses, 2003, Sirolimus-eluting stent vs standard stents in patients with stenosis in a native coronary artery, N. Engl. J. Med., 349, 1315, 10.1056/NEJMoa035071 Holmes, 2004, Analysis of 1-year clinical outcomes in the SIRIUS Trial: A randomized trial of a sirolimus-eluting stent vs a standard stent in patients at high risk for coronary restenosis, Circulation, 109, 634, 10.1161/01.CIR.0000112572.57794.22 Schofer, 2003, Sirolimus-eluting stent for the treatment of patients with long atherosclerotic lesions in small coronary arteries double blind randomized controlled trial (E-SIRIUS), Lancet, 362, 1093, 10.1016/S0140-6736(03)14462-5 Schampaert, 2004, The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS), J. Am. Coll. Cardiol., 43, 10.1016/j.jacc.2004.01.024 Serruys, 2004, For the TAXUS II study group vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial, Circulation, 109, 627, 10.1161/01.CIR.0000112566.87022.32 Gershlick, 2004, Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the european evaluation of paclitaxel eluting stent (ELUTES) Trial, Circulation, 109, 487, 10.1161/01.CIR.0000109694.58299.A0 Mathew, 2004, Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of restenosis with tranilast and its outcomes (PRESTO), Circulation, 109, 476, 10.1161/01.CIR.0000109693.64957.20 Abizaid, 2004, First human experience with the 17-beta-estradiol–eluting stent. The estrogen and stents to eliminate restenosis (EASTER) trial, J. Am. Coll. Cardiol., 43, 10.1016/j.jacc.2004.01.023 Virmani, 2004, Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?, Circulation, 109, 701, 10.1161/01.CIR.0000116202.41966.D4 Colombo, 2004, Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions, Circulation, 109, 1244, 10.1161/01.CIR.0000118474.71662.E3 Van Hout, 2002, Cost-effectiveness of the sirolimus-eluting BX Velocity stent: one year results, Eur. Heart J., 4, 691 Chevalier, 2003, De l'usage des endoprothèses coronaires, Arch. Mal. Cœur, 96, 163 Regar, 2002, Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx Velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size, Circulation, 106, 1949, 10.1161/01.CIR.0000034045.36219.12 Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N. Engl. J. Med., 345, 494, 10.1056/NEJMoa010746 Steinhubl, 2002, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial, JAMA, 288, 2411, 10.1001/jama.288.19.2411